Overactive Bladder - Results from #200

Botox rechallenge-An additional tool in the management of an incompletely emptying bladder and inadequate overactive symptom control following sacral neuromodulation. July 26, 2020

[Knowledge, practices and expectations in the management of overactive bladder in general practice and gynecology in France]. July 26, 2020

[Analysis of costs and consequences related to the persistence of Mirabegron and antimuscarinic treatments and their impact on quality of life in patients with overactive bladder in Spain: Results of a probabilistic model.] July 26, 2020

Percutaneous tibial nerve stimulation for overactive bladder syndrome: a systematic review and meta-analysis. July 25, 2020

Treatment for refractory overactive bladder: a systematic review and meta-analysis of sacral neuromodulation and onabotulinumtoxinA. July 19, 2020

Taking OAB Seriously: A Qualitative Evaluation of Primary Care Education on Overactive Bladder Syndrome Management. July 19, 2020

[Symptoms severity profile and expectations in hyperactive bladder patients - VHEXPECTA Study.] July 19, 2020

Medicinal Plants Used To Treat Overactive Bladder. July 19, 2020

Sacral nerve stimulation for refractory OAB and idiopathic urinary retention: Can phenotyping improve the outcome for patients: ICI-RS 2019? July 19, 2020

Is the addition of vaginal electrical stimulation to transcutaneous tibial nerve electrical stimulation more effective for overactive bladder treatment? A randomized controlled trial. July 19, 2020

Should we routinely assess psychological morbidities in idiopathic lower urinary tract dysfunction: ICI-RS 2019? July 17, 2020

Early and Consistent Improvements in Urinary Symptoms and Quality of Life With OnabotulinumtoxinA in Patients With Overactive Bladder and Urinary Incontinence: Results From a Randomized, Placebo-controlled, Phase IV Clinical Trial. July 17, 2020

Antimuscarinic Discontinuation in Patients with Overactive Bladder in Nursing Homes: A Retrospective Study of Medicare Beneficiaries. July 12, 2020

Factors Associated With Long-Term Use of Percutaneous Tibial Nerve Stimulation for Management of Overactive Bladder Syndrome. July 12, 2020

Effectiveness of antimuscarinics and a beta-3 adrenoceptor agonist in patients with overactive bladder in a real-world setting. July 12, 2020

Medium-term outcomes of sacral neuromodulation in patients with refractory overactive bladder: A retrospective single-institution study. July 12, 2020

Treatment of Non-neurogenic Lower Urinary Tract Symptoms-A Review of Key Publications from 2018 Onward. July 12, 2020

Clinical Factors Associated With the Feeling of Incomplete Bladder Emptying in Women With Little Postvoided Residue. July 12, 2020

Optimizing Nonsurgical Treatments of Overactive Bladder in the United States. July 5, 2020

Clinical Efficacy of Transurethral Resection of the Prostate Combined with Oral Anticholinergics or Botulinum Toxin - A Injection to Treat Benign Prostatic Hyperplasia with Overactive Bladder: A Case-Control Study. July 5, 2020

Page 11 of 98

email news signup

SUFU MyBladder app